A Phase II Trial of Fixed-Dose Rate Gemcitabine Plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients
Oncology - Switzerland
doi 10.1159/000329079
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2012
Authors
Publisher
S. Karger AG